Pharmafile Logo
Pharmafocus logo
Advanced Search
sang-jin_pak

Exclusive interview: Samsung Bioepis’ Sang-Jin Pak on the rise of biosimilars

December 2, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung Bioepis, biosimilars, pharma

Following on from our focus on biosimilars in our feature last week, you can read Nikhil Patel’s interview with Sang-Jin …

Feature
prison_bars_5997920696

FDA urged to investigate use of unapproved drug on prisoners

December 2, 2019
Sales and Marketing FDA, Opiods, US Opiods, opiod crisis

The Louisiana Department of Public Safety and Corrections (LDPSC) and BioCorRx Inc are alleged to have collaborated in testing an …

News

NICE authorises Lynparza for NHS use in all BRCA-mutated ovarian cancer cases

December 2, 2019
Sales and Marketing Cancer, NHS, NICE, lynparza, ovarian cancer, pharma

NICE has given its recommendation for the routine use on the NHS in England and Wales of AstraZeneca and MSD’s …

News
180921-drugs-pills-bottle-faeture-image

Labour and Lib Dems make election pledge for wider access to HIV drug

December 2, 2019
Sales and Marketing AIDS, Conservatives, HIV. HIV Drugs, Labour Party, Liberal Democrats, lib dems

The Labour Party and the Liberal Democrats have both pledged to roll out access to pre-exposure prophylaxis (PrEP) therapy for …

News

British pharmaceutical industry is threatened by Labour, says former Party health minister

December 2, 2019
Sales and Marketing British pharmaceuticals, Election 2019, Jeremy Corbyn, Labour Party, NHS

A former Labour Party health minister has said that the British pharmaceutical industry is “under threat” from a Jeremy Corbyn …

News

Roche’s satralizumab shows promise at Phase 3 in neuromyelitis optica spectrum disorder

December 2, 2019
Research and Development, Sales and Marketing Roche, pharma, satralizumab

Roche has presented new data on its interleukin-6 (IL-6) inhibitor satralizumab in the treatment of neuromyelitis optica spectrum disorder (NMOSD), …

News
top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

November 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, Jeremy Corbyn, NHS, Opiod, US, opiod crisis

The NHS was featured heavily in the news this week. Jeremy Corbyn revealed documents detailing previous UK-US discussions in which …

News
nhs_sign

Few in NHS trust tech firms handling patient data

November 29, 2019
Medical Communications AI, Boris, Corbyn, NHS, NHS Brexit, johnson

Few in the NHS trust ‘big tech’ companies to handle patient data in a confidential manner, a recent YouGov poll …

News
26682732344_ae569bf0e3_b

Immupharma and Avion sign agreement for lupus drug Lupuzor

November 29, 2019
Medical Communications Diseases, Lupus, Lupuzor, avion

Immupharma has signed a development agreement with Avion Pharmaceuticals to acquire the licensing rights for Lupuzor, a peptide therapeutic and …

News
indian_pharma

Study shows widespread bribery in Indian pharmaceutical industry

November 29, 2019
Medical Communications India, Indian Pharma, Modi, bribery

A recent report by the Support for Advocacy and Training to Health Initiatives (Sathi) revealed the widespread use of bribes …

News

FDA gives priority review for AstraZeneca’s Imfinzi

November 29, 2019
Medical Communications AstraZeneca, Cancer, FDA, Imfinzi, lung cancer

The FDA has granted a priority review of AstraZeneca’s cancer treatment drug Imfinzi (durvalumab) for treatment of patients with untreated …

News
merck-keytruda

Prostate Cancer ‘super responders’ could live for two more years on Keytruda

November 28, 2019
Research and Development Cancer, immunotherapy, keytruda, oncology, prostate cancer

Men with advanced prostate cancer, who have exhausted all treatment options, could use the immunotherapy Keytruda (pembrolizumab) to live for …

News
ususnsu

Majority of British people worried about the fate of the NHS in post-Brexit US trade deal, survey reveals

November 28, 2019
Medical Communications Boris Johnson, Jeremy Corbyn, NHS, Trump, brexit, european union

In a newly released survey on “Over-The-Counter (OTC) and Pharma 2019”, by the business data platform Statista, 55% of people …

News
34778112_496a002303_b

Drugmakers cut prices by 61% to get on Chinese reimbursement list

November 28, 2019
Manufacturing and Production AstraZeneca, China, China National Reimbursement Scheme, Novartis, Roche Holding

AstraZeneca and Roche Holding are among a number of drugmakers to cut their prices in order to get on China’s …

News
pfizer_building_logo1_19

Pfizer’s Ibrance approved by NICE, to be added to the Cancer Drugs Fund

November 28, 2019
Manufacturing and Production, Research and Development Cancer Drugs Fund, NHS, NICE, Pfizer, breast cancer, ibrance, pharma

Today it was announced that the National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Ibrance (palbociclib) to …

News

US prosecutors open criminal probe of six drugs companies in opioid investigation

November 28, 2019
Business Services, Manufacturing and Production Federal Substance Act, Opiod, Trump, Trump Opiod, opiod crisis

Federal Prosecutors from the US Attorney’s Office in the Eastern District of New York have subpoenaed five opioid manufactures. The …

News
corbyn_nhs

Corbyn reveals documents showing US-UK meetings on deregulating NHS drug pricing

November 27, 2019
Research and Development, Sales and Marketing Jeremy Corbyn, Labour Party, NHS, US, pharma

Labour Leader Jeremy Corbyn has showed off documents that detail secret trade meetings between the US and UK Governments, where …

News
immagine-1

Organisation of Islamic Cooperation sets up new halal pharmaceuticals technical committee

November 27, 2019
Research and Development Arabic, Halal, Organisation of Islamic Cooperation, Saudi Arabia, malaysia

The Organisation of Islamic Cooperation’s (OIC) standards body, the Standards and Metrology Institute for Islamic Countries (SMIIC), has set up …

News
shutterstock_79370437

New ICER report reveals most cost-effective rheumatoid arthritis therapies

November 27, 2019
Research and Development, Sales and Marketing AbbVie, Eli Lilly, Humira, Olumiant, Pfizer, Rinvoq, Xeljanz, pharma

The Institute for Clinical and Economic Review (ICER) has unveiled a new report comparing the clinical efficacy and cost-effectiveness of …

News
images

NICE rejects Keytruda for routine use in NHS bladder cancer treatment

November 27, 2019
Research and Development Cancer Drugs Fund, bladder cancer, cancer research

The National Institute for Health and Care Excellence (NICE) has given an initial ‘no’ for Keytruda’s (pembrolizumab) use in treating …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025